Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stifel Maintains Buy on Zymeworks BC, Lowers Price Target to $18

Stifel Maintains Buy on Zymeworks BC, Lowers Price Target to $18

Stifel analyst Stephen Willey maintains Zymeworks BC (NYSE:ZYME) with a Buy and lowers the price target from $21 to $18.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Stifel analyst Stephen Willey maintains Zymeworks BC (NYSE:ZYME) with a Buy and lowers the price target from $21 to $18.

U.S. Stocks Turn Higher; Nasdaq Rises 50 Points

By Lisa Levin

August 18, 12:00 PM

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday.

BBBY

Guggenheim Maintains Buy on Eli Lilly, Raises Price Target to $401

By Benzinga Newsdesk

December 7, 10:27 AM

Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $399 to $401.

LLY

BellRing Brands Q4 Adj. EPS $0.31 Beats $0.29 Estimate, Sales $379.20M Miss $400.40M Estimate

By Bill Haddad

November 17, 6:02 PM

BellRing Brands (NYSE:BRBR) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.29 by 6.9 percent. This is a 24 percent increase over earnings of $0.25 per share from the same

BRBR

Why Sonos Stock Is Surging Thursday

By Adam Eckert

November 16, 12:03 PM

Sonos Inc (NASDAQ: SONO) shares are trading higher Thursday after the company reported better-than-expected financial results and announced

SONO

Stifel Maintains Buy on Zymeworks BC, Lowers Price Target to $18

Related Posts

U.S. Stocks Turn Higher; Nasdaq Rises 50 Points

Guggenheim Maintains Buy on Eli Lilly, Raises Price Target to $401

BellRing Brands Q4 Adj. EPS $0.31 Beats $0.29 Estimate, Sales $379.20M Miss $400.40M Estimate

Why Sonos Stock Is Surging Thursday